The demise of HRT? The long-term safety of hormone replacement therapy.
The role of hormone replacement therapy (HRT) in the health of middle-aged women has come a full circle. HRT has been widely accepted as the treatment of choice for the management of menopausal symptoms. However, the Women's Health Initiative (WHI) and other recent randomised controlled trials have failed to confirm beliefs of other potential benefits in reducing the risk of coronary artery disease (CAD) and stroke. Indeed, early increases in cardiac event and stroke rate have been seen in women taking combination HRT. An increased risk of breast cancer diagnosis has also been confirmed in HRT users. The use of HRT now needs to be regarded as a short-term therapy for menopausal symptom management with treatment individualised for each woman.
Fenton
Anna
A
D001943:Breast Neoplasms / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000139:chemically induced / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause; D011372:Progestins / Q000009:adverse effects; D018570:Risk Assessment; D020521:Stroke / Q000139:chemically induced / Q000517:prevention & control
D004967:Estrogens; D011372:Progestins